Supplemental Material, sj-docx-1-cpt-10.1177_10742484221142220 - Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis

sj-docx-1-taj-10.1177_20406223221108397 – Supplemental material for The dynamics of the general practitioner-nephrologist collaboration for the management of patients with chronic kidney disease before and after dialysis initiation: a mixed-methods study

Maxime Raffray (13888188)
Cécile Vigneau (2615374)
Cécile Couchoud (682106)
Laetitia Laude (13888191)
Arnaud Campéon (13888194)
François-Xavier Schweyer (13044673)
Sahar Bayat (456352)

September 2022

Supplemental material, sj-docx-1-taj-10.1177_20406223221108397 for The dynamics of the general pract...

Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET

Grandone, Elvira
Aucella, Filippo
Barcellona, Doris
Brunori, Giuliano
Forneris, Giacomo
Gresele, Paolo
Marietta, Marco
Poli, Daniela
Testa, Sophie
Tripodi, Armando
Genovesi, Simonetta C

January 2020

Direct oral anticoagulants (DOAC) are mostly prescribed to prevent cardioembolic stroke in patients ...

Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET

Grandone, Elvira
Aucella, Filippo
Barcellona, Doris
Brunori, Giuliano
Forneris, Giacomo
Gresele, Paolo
Marietta, Marco
Poli, Daniela
Testa, Sophie
Tripodi, Armando
Genovesi, Simonetta C

January 2020

Direct oral anticoagulants (DOAC) are mostly prescribed to prevent cardioembolic stroke in patients ...

sj-docx-1-aop-10.1177_10600280221129348 – Supplemental material for Direct Oral Anticoagulants Versus Warfarin for Venous Thromboembolism Prophylaxis in Patients With Nephrotic Syndrome: A Retrospective Cohort Study

Aminat Tijani (13927674)
Eric M. Coons (13927677)
Britta Mizuki (13927680)
Miranda Dermady (13927683)
Katerina Stanilova (13927686)
Ashley L. Casey (13927689)
Muhannad Alqudsi (13927692)
Mariella Gastanaduy (13927695)
Ardem Elmayan (6878066)
Adi Bamnolker (13927698)
Juan Carlos Q. Velez (13927701)

October 2022

Supplemental material, sj-docx-1-aop-10.1177_10600280221129348 for Direct Oral Anticoagulants Versus...

sj-docx-2-aop-10.1177_10600280221129348 – Supplemental material for Direct Oral Anticoagulants Versus Warfarin for Venous Thromboembolism Prophylaxis in Patients With Nephrotic Syndrome: A Retrospective Cohort Study

Aminat Tijani (13927674)
Eric M. Coons (13927677)
Britta Mizuki (13927680)
Miranda Dermady (13927683)
Katerina Stanilova (13927686)
Ashley L. Casey (13927689)
Muhannad Alqudsi (13927692)
Mariella Gastanaduy (13927695)
Ardem Elmayan (6878066)
Adi Bamnolker (13927698)
Juan Carlos Q. Velez (13927701)

October 2022

Supplemental material, sj-docx-2-aop-10.1177_10600280221129348 for Direct Oral Anticoagulants Versus...

sj-docx-1-cjk-10.1177_20543581221149621 – Supplemental material for Population-Based Analysis of Nonsteroidal Anti-inflammatory Drug Prescription in Subjects With Chronic Kidney Disease

Marni J. Armstrong (14451293)
Kevin Zhang (3961157)
Feng Ye (173489)
Scott W. Klarenbach (12994120)
Neesh I. Pannu (14451296)

January 2023

Supplemental material, sj-docx-1-cjk-10.1177_20543581221149621 for Population-Based Analysis of Nons...

sj-docx-1-aop-10.1177_10600280221139248 – Supplemental material for The Safety of Direct Oral Anticoagulants Compared to Warfarin in Patients Hospitalized With Acute Kidney Injury

Felicia A. Harrsch (14240682)
Jennifer L. Walls (14240685)
Kathleen M. Makkar (14240688)

December 2022

Supplemental material, sj-docx-1-aop-10.1177_10600280221139248 for The Safety of Direct Oral Anticoa...

sj-xlsx-2-cjk-10.1177_20543581221149621 – Supplemental material for Population-Based Analysis of Nonsteroidal Anti-inflammatory Drug Prescription in Subjects With Chronic Kidney Disease

Marni J. Armstrong (14451293)
Kevin Zhang (3961157)
Feng Ye (173489)
Scott W. Klarenbach (12994120)
Neesh I. Pannu (14451296)

January 2023

Supplemental material, sj-xlsx-2-cjk-10.1177_20543581221149621 for Population-Based Analysis of Nons...

sj-docx-2-cpt-10.1177_10742484231212106 - Supplemental material for Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality

Łukasz Pyka (2544997)
Bartosz Hudzik (17713473)
Stanisław Bartuś (5807255)
Paweł Buszman (17713476)
Marek Gierlotka (2547961)
Wojciech Wojakowski (3712555)
Jarosław Hiczkiewicz (13948143)
Andrzej Kleinrok (17713479)
Michał Skrzypek (8711586)
Wiktor Kuliczkowski (285682)
Mariusz Gąsior (2544994)

December 2023

Supplemental material, sj-docx-2-cpt-10.1177_10742484231212106 for Anticoagulation for Atrial Fibril...

sj-docx-1-imj-10.1177_10815589231208478 – Supplemental material for Atrial fibrillation mortality trends in individuals with heart failure

Ramzi Ibrahim (17377558)
Vikram J Singh (17377561)
Simar J Singh (17377564)
Ayman Hussein (10974604)
Justin Z Lee (17377567)

November 2023

Supplemental material, sj-docx-1-imj-10.1177_10815589231208478 for Atrial fibrillation mortality tre...

Direct oral anticoagulants in patients with atrial fibrillation and renal dysfunction

Kobalava Z.D.
Shavarov A.A.
Vatsik-Gorodetskaya M.V.

Atrial fibrillation and renal dysfunction often coexist, each disorder may predispose to the other a...

supplementary_figure_1 - Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis

Ajoe John Kattoor (6654083)
Naga Venkata Pothineni (6654086)
Akshay Goel (6654089)
Mahanazuddin Syed (6654092)
Shorabuddin Syed (6654095)
Hakan Paydak (6654098)
Jawahar L. Mehta (126307)

April 2019

supplementary_figure_1 for Prescription Patterns and Outcomes of Patients With Atrial Fibrillation T...

sj-pdf-1-cpt-10.1177_10742484231212106 - Supplemental material for Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality

Łukasz Pyka (2544997)
Bartosz Hudzik (17713473)
Stanisław Bartuś (5807255)
Paweł Buszman (17713476)
Marek Gierlotka (2547961)
Wojciech Wojakowski (3712555)
Jarosław Hiczkiewicz (13948143)
Andrzej Kleinrok (17713479)
Michał Skrzypek (8711586)
Wiktor Kuliczkowski (285682)
Mariusz Gąsior (2544994)

December 2023

Supplemental material, sj-pdf-1-cpt-10.1177_10742484231212106 for Anticoagulation for Atrial Fibrill...

sj-docx-1-taj-10.1177_20406223231213262 – Supplemental material for Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study

Ye Ji (287719)
Baoyan Wang (1858972)
Guangyan Wu (6619259)
Yepeng Zhang (12394123)
Qing Wang (27728)
Min Zhou (173135)

December 2023

Supplemental material, sj-docx-1-taj-10.1177_20406223231213262 for Comparison of rivaroxaban-based d...

Oral Anticoagulant Treatment of Atrial Fibrillation in Chronic Kidney Disease Patients

GÜRSU, Meltem
KAZANCIOĞLU, Rümeyza
ELÇİOĞLU, Ömer Celal
Artan, Ayşe Serra

January 2019

Nonvalvular atrial fibrillation is the most prevalent sustained arrhythmia in chronic kidney disease...

sj-docx-1-taj-10.1177_20406223221108397 – Supplemental material for The dynamics of the general practitioner-nephrologist collaboration for the management of patients with chronic kidney disease before and after dialysis initiation: a mixed-methods study

Maxime Raffray (13888188)
Cécile Vigneau (2615374)
Cécile Couchoud (682106)
Laetitia Laude (13888191)
Arnaud Campéon (13888194)
François-Xavier Schweyer (13044673)
Sahar Bayat (456352)

September 2022

Supplemental material, sj-docx-1-taj-10.1177_20406223221108397 for The dynamics of the general pract...

Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET

Grandone, Elvira
Aucella, Filippo
Barcellona, Doris
Brunori, Giuliano
Forneris, Giacomo
Gresele, Paolo
Marietta, Marco
Poli, Daniela
Testa, Sophie
Tripodi, Armando
Genovesi, Simonetta C

January 2020

Direct oral anticoagulants (DOAC) are mostly prescribed to prevent cardioembolic stroke in patients ...

Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET

Grandone, Elvira
Aucella, Filippo
Barcellona, Doris
Brunori, Giuliano
Forneris, Giacomo
Gresele, Paolo
Marietta, Marco
Poli, Daniela
Testa, Sophie
Tripodi, Armando
Genovesi, Simonetta C

January 2020

Direct oral anticoagulants (DOAC) are mostly prescribed to prevent cardioembolic stroke in patients ...

sj-docx-1-aop-10.1177_10600280221129348 – Supplemental material for Direct Oral Anticoagulants Versus Warfarin for Venous Thromboembolism Prophylaxis in Patients With Nephrotic Syndrome: A Retrospective Cohort Study

Aminat Tijani (13927674)
Eric M. Coons (13927677)
Britta Mizuki (13927680)
Miranda Dermady (13927683)
Katerina Stanilova (13927686)
Ashley L. Casey (13927689)
Muhannad Alqudsi (13927692)
Mariella Gastanaduy (13927695)
Ardem Elmayan (6878066)
Adi Bamnolker (13927698)
Juan Carlos Q. Velez (13927701)

October 2022

Supplemental material, sj-docx-1-aop-10.1177_10600280221129348 for Direct Oral Anticoagulants Versus...

sj-docx-2-aop-10.1177_10600280221129348 – Supplemental material for Direct Oral Anticoagulants Versus Warfarin for Venous Thromboembolism Prophylaxis in Patients With Nephrotic Syndrome: A Retrospective Cohort Study

Aminat Tijani (13927674)
Eric M. Coons (13927677)
Britta Mizuki (13927680)
Miranda Dermady (13927683)
Katerina Stanilova (13927686)
Ashley L. Casey (13927689)
Muhannad Alqudsi (13927692)
Mariella Gastanaduy (13927695)
Ardem Elmayan (6878066)
Adi Bamnolker (13927698)
Juan Carlos Q. Velez (13927701)

October 2022

Supplemental material, sj-docx-2-aop-10.1177_10600280221129348 for Direct Oral Anticoagulants Versus...

sj-docx-1-cjk-10.1177_20543581221149621 – Supplemental material for Population-Based Analysis of Nonsteroidal Anti-inflammatory Drug Prescription in Subjects With Chronic Kidney Disease

Marni J. Armstrong (14451293)
Kevin Zhang (3961157)
Feng Ye (173489)
Scott W. Klarenbach (12994120)
Neesh I. Pannu (14451296)

January 2023

Supplemental material, sj-docx-1-cjk-10.1177_20543581221149621 for Population-Based Analysis of Nons...

sj-docx-1-aop-10.1177_10600280221139248 – Supplemental material for The Safety of Direct Oral Anticoagulants Compared to Warfarin in Patients Hospitalized With Acute Kidney Injury

Felicia A. Harrsch (14240682)
Jennifer L. Walls (14240685)
Kathleen M. Makkar (14240688)

December 2022

Supplemental material, sj-docx-1-aop-10.1177_10600280221139248 for The Safety of Direct Oral Anticoa...

sj-xlsx-2-cjk-10.1177_20543581221149621 – Supplemental material for Population-Based Analysis of Nonsteroidal Anti-inflammatory Drug Prescription in Subjects With Chronic Kidney Disease

Marni J. Armstrong (14451293)
Kevin Zhang (3961157)
Feng Ye (173489)
Scott W. Klarenbach (12994120)
Neesh I. Pannu (14451296)

January 2023

Supplemental material, sj-xlsx-2-cjk-10.1177_20543581221149621 for Population-Based Analysis of Nons...

sj-docx-2-cpt-10.1177_10742484231212106 - Supplemental material for Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality

Łukasz Pyka (2544997)
Bartosz Hudzik (17713473)
Stanisław Bartuś (5807255)
Paweł Buszman (17713476)
Marek Gierlotka (2547961)
Wojciech Wojakowski (3712555)
Jarosław Hiczkiewicz (13948143)
Andrzej Kleinrok (17713479)
Michał Skrzypek (8711586)
Wiktor Kuliczkowski (285682)
Mariusz Gąsior (2544994)

December 2023

Supplemental material, sj-docx-2-cpt-10.1177_10742484231212106 for Anticoagulation for Atrial Fibril...

sj-docx-1-imj-10.1177_10815589231208478 – Supplemental material for Atrial fibrillation mortality trends in individuals with heart failure

Ramzi Ibrahim (17377558)
Vikram J Singh (17377561)
Simar J Singh (17377564)
Ayman Hussein (10974604)
Justin Z Lee (17377567)

November 2023

Supplemental material, sj-docx-1-imj-10.1177_10815589231208478 for Atrial fibrillation mortality tre...

Direct oral anticoagulants in patients with atrial fibrillation and renal dysfunction

Kobalava Z.D.
Shavarov A.A.
Vatsik-Gorodetskaya M.V.

Atrial fibrillation and renal dysfunction often coexist, each disorder may predispose to the other a...

supplementary_figure_1 - Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis

Ajoe John Kattoor (6654083)
Naga Venkata Pothineni (6654086)
Akshay Goel (6654089)
Mahanazuddin Syed (6654092)
Shorabuddin Syed (6654095)
Hakan Paydak (6654098)
Jawahar L. Mehta (126307)

April 2019

supplementary_figure_1 for Prescription Patterns and Outcomes of Patients With Atrial Fibrillation T...

sj-pdf-1-cpt-10.1177_10742484231212106 - Supplemental material for Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality

Łukasz Pyka (2544997)
Bartosz Hudzik (17713473)
Stanisław Bartuś (5807255)
Paweł Buszman (17713476)
Marek Gierlotka (2547961)
Wojciech Wojakowski (3712555)
Jarosław Hiczkiewicz (13948143)
Andrzej Kleinrok (17713479)
Michał Skrzypek (8711586)
Wiktor Kuliczkowski (285682)
Mariusz Gąsior (2544994)

December 2023

Supplemental material, sj-pdf-1-cpt-10.1177_10742484231212106 for Anticoagulation for Atrial Fibrill...

sj-docx-1-taj-10.1177_20406223231213262 – Supplemental material for Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study

Ye Ji (287719)
Baoyan Wang (1858972)
Guangyan Wu (6619259)
Yepeng Zhang (12394123)
Qing Wang (27728)
Min Zhou (173135)

December 2023

Supplemental material, sj-docx-1-taj-10.1177_20406223231213262 for Comparison of rivaroxaban-based d...

Oral Anticoagulant Treatment of Atrial Fibrillation in Chronic Kidney Disease Patients

GÜRSU, Meltem
KAZANCIOĞLU, Rümeyza
ELÇİOĞLU, Ömer Celal
Artan, Ayşe Serra

January 2019

Nonvalvular atrial fibrillation is the most prevalent sustained arrhythmia in chronic kidney disease...

sj-docx-1-taj-10.1177_20406223221108397 – Supplemental material for The dynamics of the general practitioner-nephrologist collaboration for the management of patients with chronic kidney disease before and after dialysis initiation: a mixed-methods study

Maxime Raffray (13888188)
Cécile Vigneau (2615374)
Cécile Couchoud (682106)
Laetitia Laude (13888191)
Arnaud Campéon (13888194)
François-Xavier Schweyer (13044673)
Sahar Bayat (456352)

September 2022

Supplemental material, sj-docx-1-taj-10.1177_20406223221108397 for The dynamics of the general pract...

Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET

Grandone, Elvira
Aucella, Filippo
Barcellona, Doris
Brunori, Giuliano
Forneris, Giacomo
Gresele, Paolo
Marietta, Marco
Poli, Daniela
Testa, Sophie
Tripodi, Armando
Genovesi, Simonetta C

January 2020

Direct oral anticoagulants (DOAC) are mostly prescribed to prevent cardioembolic stroke in patients ...

Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET

Grandone, Elvira
Aucella, Filippo
Barcellona, Doris
Brunori, Giuliano
Forneris, Giacomo
Gresele, Paolo
Marietta, Marco
Poli, Daniela
Testa, Sophie
Tripodi, Armando
Genovesi, Simonetta C

January 2020

Direct oral anticoagulants (DOAC) are mostly prescribed to prevent cardioembolic stroke in patients ...

Supplemental Material, sj-docx-1-cpt-10.1177_10742484221142220 - Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis

Abstract

Extracted data

Supplemental Material, sj-docx-1-cpt-10.1177_10742484221142220 - Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis

Abstract

Extracted data

Related items

Related items